April 30, 2026
A growth-style fund seeking long-term increases from around the world.
Is this fund right for you?
- You want your money to grow over a longer term.
- You want to invest in companies around the world, with a focus on developed markets.
- You're comfortable with a medium level of risk.
RISK RATING
How is the fund invested? (as of February 28, 2026)
| Name | Percent |
|---|---|
| US Equity | 64.2 |
| International Equity | 31.0 |
| Canadian Equity | 2.7 |
| Cash and Equivalents | 2.0 |
| Other | 0.1 |
| Name | Percent |
|---|---|
| United States | 64.2 |
| United Kingdom | 6.1 |
| France | 5.1 |
| Canada | 4.7 |
| Taiwan | 4.0 |
| Switzerland | 2.7 |
| Ireland | 2.3 |
| China | 1.7 |
| Netherlands | 1.6 |
| Other | 7.6 |
| Name | Percent |
|---|---|
| Technology | 34.8 |
| Healthcare | 12.7 |
| Industrial Goods | 11.8 |
| Consumer Services | 10.0 |
| Financial Services | 9.1 |
| Basic Materials | 7.9 |
| Consumer Goods | 6.7 |
| Industrial Services | 3.3 |
| Cash and Cash Equivalent | 2.0 |
| Other | 1.7 |
Growth of $10,000 (since inception)
For the period 07/12/2016 through 04/30/2026 tr.with $10,000 CAD investment, The value of the investment would be $24,906
Fund details (as of February 28, 2026)
| Top holdings | Percent (%) |
|---|---|
| Alphabet Inc Cl A | 5.0 |
| Apple Inc | 4.6 |
| NVIDIA Corp | 4.3 |
| Meta Platforms Inc Cl A | 4.2 |
| Microsoft Corp | 3.7 |
| Mastercard Inc Cl A | 2.9 |
| Eli Lilly and Co | 2.5 |
| Linde PLC | 2.4 |
| Taiwan Semiconductor Manufactrg Co Ltd - ADR | 2.3 |
| Johnson & Johnson | 2.1 |
| Total allocation in top holdings | 34.0 |
| Portfolio characteristics | Value |
|---|---|
| Standard deviation | 10.6% |
| Dividend yield | 1.1% |
| Yield to maturity | - |
| Duration (years) | - |
| Coupon | - |
| Average credit rating | Not rated |
| Average market cap (million) | $1,437,648.0 |
Understanding returns
Annual compound returns (%)
| 1 MO | 3 MO | YTD | 1 YR |
|---|---|---|---|
| 5.4 | -1.2 | 1.6 | 4.2 |
| 3 YR | 5 YR | 10 YR | INCEPTION |
|---|---|---|---|
| 7.1 | 4.5 | - | 9.8 |
Calendar year returns (%)
| 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|
| -1.3 | 15.5 | 14.3 | -20.3 |
| 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|
| 24.5 | 20.5 | 24.4 | 0.3 |
Range of returns over five years (August 01, 2016 - April 30, 2026)
| Best return | Best period end date | Worst return | Worst period end date |
|---|---|---|---|
| 17.9% | Dec 2021 | 4.2% | Mar 2026 |
| Average return | % of periods with positive returns | Number of positive periods | Number of negative periods |
|---|---|---|---|
| 9.7% | 100 | 58 | 0 |
Q1 2026 Fund Commentary
Commentary and opinions are provided by Mackenzie Investments.
Market commentary
The global economy navigated a turbulent first quarter. Markets began 2026 on a positive note, with investor sentiment buoyed by continued disinflation, stable corporate earnings and expectations for further monetary easing. The outlook shifted dramatically in late February after the conflict in the Middle East escalated, and the Strait of Hormuz was effectively closed in early March, disrupting a significant share of global oil supply and raising fears of an energy-driven inflation shock.
Major central banks responded with caution. The U.S. Federal Reserve Board and the Bank of Canada both held rates unchanged at their January and March meetings. The European Central Bank postponed planned interest rate reductions and raised its inflation forecast after energy prices surged. These developments signaled that monetary easing cycles could be delayed or disrupted by the geopolitical shock.
Global equity markets declined in the first quarter, with the MSCI World Index falling about 3.5%. The U.S. market weighed most heavily on results as large-cap technology stocks retreated amid rising inflation concerns. Japanese equities benefited from ongoing corporate governance reforms. Emerging markets ended the quarter roughly flat, as higher import costs in oil-importing economies in Asia partly offset gains in commodity-exporting markets.
Performance
Stock selection in the information technology sector was the top contributor to the Fund’s performance. Linde PLC and Keysight Technologies Inc. were the top individual contributors to performance.
An underweight allocation to the energy sector detracted the most from performance. Waste Connections Inc. and Roper Technologies Inc. were the top individual detractors from performance.
Portfolio activity
The sub-advisor added AstraZeneca PLC and Keysight Technologies Inc. to the Fund. The sub-advisor also increased Texas Instruments Inc. and Caterpillar Inc.
The sub-advisor sold Copart Inc. and Symrise AG. The sub-advisor reduced Waste Connections Inc.